When comparing the clinico-pathological characteristics of patients with TNBC and HER2-positive BC, we observed, as expected14,15, a higher proportion of axillary lymph node metastases at diagnosis in patients with HER2-positive tumors compared to patients with TNBC (Supplementary Table 1). This evidence concerns the gene ERBB2 and breast cancer.